VaccinationsNCT05329506
Attitudes and Believes About Vaccinations in a Supportive Care Patient Population
An observational study of Vaccinations, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Vaccinations
- What is being tested?
- patient population
- Type of treatment
- Vaccines
- How many people
- 104 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Mar 2022to 15 Jul 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: M D Anderson Cancer Center
Who may be able to join
- Patients who are seen as part of a clinic visit with the Supportive Care Clinic at M.D.
- Anderson Cancer Center, also patients who are being seen by the inpatient Supportive Medicine Consultation Service.
- Patients who are 18 years of age or older
- Patients who are able to speak English.
Who cannot join
- Patients who are unable to sign written consent
- Patients who are considered delirious at the time of the clinic encounter as defined by a Memorial Delirium Assessment Scale score of 7 or greater. The nursing staff, as a part of the patient intake process and routine care, performs the delirium assessment for clinic patients.
Trial locations and contacts
1 site in 1 country.
About this study
To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care.
Read the detailed description
Primary Objective:
Our primary objective is to assess patient perception of efficacy and safety of vaccinations.
Secondary Objectives:
To assess demographic predictors of those who would be considered as vaccine hesitant.
To assess patient preferred source of recommendations for or against vaccination.
To assess the role past side effects or allergic reactions play on patient perception of future vaccines.
To assess patient perception of vaccination prior to COVID-19.
To assess patient willingness to get the COVID-19 vaccine.
To assess patient willingness to get the influenza vaccine.
- Conditions
- Vaccinations
- Being tested
- patient population
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
patient populationOther
questionnaires, standard of care
| Study group | Role | What they receive |
|---|---|---|
| Supportive care patient population | Attitudes and Believes About Vaccinations, questionnaires Receives: Other: patient population |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exploratory survey evaluating the solely patient's opinions and perceptions regarding the safety and efficacy of vaccinations for Parent Attitudes about Childhood Vaccines (PACV-4 scale) with a score of 2 or greater.
We will assess the patient's opinion and perception of the safety of vaccinations based upon a questionnaire and a Likert scale of responses.
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Apr 2022
- Study start10 Mar 2022
- Primary completion15 Jul 2024
- Study completion15 Jul 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for VaccinationsStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 104 participants (actual)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Michael Tang, MD, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05329506
- Sponsor's protocol ID
- 2021-1070
- Other IDs
- NCI-2022-00365
- Status last verified
- Apr 2024
- First submitted
- 8 Mar 2022
- Last updated
- 17 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Attitudes and Believes About Vaccinations in a Supportive Care Patient Population
- ClinicalTrials.gov ID
- NCT05329506
- Acronym / sponsor ID
- 2021-1070
- Conditions
- Vaccinations
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 104 participants (actual)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Study start
- 10 Mar 2022 (actual)
- Primary completion
- 15 Jul 2024 (actual)
- Study completion
- 15 Jul 2024 (actual)
- First posted
- 15 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care.
Detailed description
Primary Objective:
Our primary objective is to assess patient perception of efficacy and safety of vaccinations.
Secondary Objectives:
To assess demographic predictors of those who would be considered as vaccine hesitant.
To assess patient preferred source of recommendations for or against vaccination.
To assess the role past side effects or allergic reactions play on patient perception of future vaccines.
To assess patient perception of vaccination prior to COVID-19.
To assess patient willingness to get the COVID-19 vaccine.
To assess patient willingness to get the influenza vaccine.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Supportive care patient population | – | Other: patient populationAttitudes and Believes About Vaccinations, questionnaires |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- M D Anderson Cancer Center
Key inclusion criteria (4 listed)
- Patients who are seen as part of a clinic visit with the Supportive Care Clinic at M.D.
- Anderson Cancer Center, also patients who are being seen by the inpatient Supportive Medicine Consultation Service.
- Patients who are 18 years of age or older
- Patients who are able to speak English.
Key exclusion criteria (2 listed)
- Patients who are unable to sign written consent
- Patients who are considered delirious at the time of the clinic encounter as defined by a Memorial Delirium Assessment Scale score of 7 or greater. The nursing staff, as a part of the patient intake process and routine care, performs the delirium assessment for clinic patients.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| patient populationquestionnaires, standard of care | Other | Supportive care patient population |
Primary outcome
Exploratory survey evaluating the solely patient's opinions and perceptions regarding the safety and efficacy of vaccinations for Parent Attitudes about Childhood Vaccines (PACV-4 scale) with a score of 2 or greater.
Time frame: through study completion, an average of 1 year
We will assess the patient's opinion and perception of the safety of vaccinations based upon a questionnaire and a Likert scale of responses.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2024.
- M D Anderson Cancer CenterLink provided by the sponsor.
Related trials for Vaccinations
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruitingPhase 4
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Immunization, HPV Infection
Recruiting
Assessment of Communication Interventions on Vaccination Knowledge and Acceptance
Vaccination Knowledge and Acceptance, Informed Vaccine-decision Making
Active, not recruiting
Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement
COVID-19
RecruitingPhase 2
Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
Diarrhoea
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michael Tang, MD principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vaccinations, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exploratory survey evaluating the solely patient's opinions and perceptions regarding the safety and efficacy of vaccinations for Parent Attitudes about Childhood Vaccines (PACV-4 scale) with a score of 2 or greater. (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2024.